2021 |
Costa S, Fairfield H, Farrell M, Murphy CS, Soucy A, Vary C, Holdsworth G, Reagan MR. Sclerostin antibody increases trabecular bone and bone mechanical properties by increasing osteoblast activity damaged by whole-body irradiation in mice. Bone. June 2021;147:115918. |
1 |
1 |
2023 |
Mountain RV, Langlais AL, Hu D, Baron R, Lary CW, Motyl KJ. Social isolation through single housing negatively affects trabecular and cortical bone in adult male, but not female, C57BL/6J mice. Bone. July 2023;172:116762. |
0 |
0 |
2021 |
Farrell M, Fairfield H, Costa S, D'Amico A, Falank C, Brooks DJ, Reagan MR. Sclerostin‐neutralizing antibody treatment rescues negative effects of rosiglitazone on mouse bone parameters. J Bone Miner Res. January 2021;36(1):158-169. |
0 |
0 |
2022 |
Treyball A, Bergeron AC, Brooks DJ, Langlais AL, Hashmi H, Nagano K, Barlow D, Neilson RJ, Roy TA, Nevola KT, Houseknecht KL, Baron R, Bouxsein ML, Guntur AR, Motyl KJ. Propranolol promotes bone formation and limits resorption through novel mechanisms during anabolic parathyroid hormone treatment in female C57BL/6J mice. J Bone Miner Res. May 2022;37(5):954-971. |
1 |
0 |
2022 |
Carvalho AL, Brooks DJ, Barlow D, Langlais AL, Morrill B, Houseknecht KL, Bouxsein ML, Lian JB, King T, Farina NH, Motyl KJ. Sustained morphine delivery suppresses bone formation and alters metabolic and circulating miRNA profiles in male C57BL/6J mice. J Bone Miner Res. November 2022;37(11):2226-2243. |
0 |
0 |